Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642.
about
Addition of drug/s to a chemotherapy regimen for metastatic breast cancerAddition of drug/s to a chemotherapy regimen for metastatic breast cancerPlatinum containing regimens for metastatic breast cancerPlatinum containing regimens for metastatic breast cancer.Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trials.Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer.Platinum-containing regimens for metastatic breast cancer.6-Methoxyethylamino-numonafide inhibits hepatocellular carcinoma xenograft growth as a single agent and in combination with sorafenib.
P2860
Q24236594-E15F0465-0875-4F70-B5A1-0AD2B56A676BQ24245443-95F5801E-DFBF-4BEA-A750-A3FBEA836D74Q24247134-D552FA3D-FB39-4FA5-A977-783542ECC1C7Q33202218-860AA5E7-F932-454F-80A2-8D07B14ED230Q36171900-A24F3F8E-E7C5-465E-8E3F-2D7C7A5FB582Q37344525-97515702-4C90-4FF0-AB1F-B7DB0ED017ABQ38712631-604D01D9-EFF9-40D3-B853-4DE0252F7193Q40087588-0729C7BA-00A1-41E0-ADB3-077A13D87719
P2860
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Safety and efficacy of using a ...... cer and Leukemia Group B 8642.
@en
Safety and efficacy of using a ...... cer and Leukemia Group B 8642.
@nl
type
label
Safety and efficacy of using a ...... cer and Leukemia Group B 8642.
@en
Safety and efficacy of using a ...... cer and Leukemia Group B 8642.
@nl
prefLabel
Safety and efficacy of using a ...... cer and Leukemia Group B 8642.
@en
Safety and efficacy of using a ...... cer and Leukemia Group B 8642.
@nl
P2093
P1476
Safety and efficacy of using a ...... cer and Leukemia Group B 8642.
@en
P2093
C Cirrincione
I C Henderson
M E Costanza
O R McIntyre
R L Schilsky
P304
P356
10.1200/JCO.1999.17.5.1397
P407
P50
P577
1999-05-01T00:00:00Z